Characterization of the condensin component Cnap1 and protein kinase Melk as novel E2F target genes down-regulated by 1,25-dihydroxyvitamin D3.
about
The CHR site: definition and genome-wide identification of a cell cycle transcriptional elementDistinct pigmentary and melanocortin 1 receptor-dependent components of cutaneous defense against ultraviolet radiation.C/EBPδ gene targets in human keratinocytes.Gene expression modifications in Wharton's Jelly mesenchymal stem cells promoted by prolonged in vitro culturingDifferential network analysis applied to preoperative breast cancer chemotherapy response.1,25-dihydroxyvitamin D3 influences cellular homocysteine levels in murine preosteoblastic MC3T3-E1 cells by direct regulation of cystathionine β-synthase.MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cellsVitamin D and human health: lessons from vitamin D receptor null mice.Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cellsRole of cell cycle regulatory molecules in retinoic acid- and vitamin D3-induced differentiation of acute myeloid leukaemia cells.Maternal dietary protein restriction and excess affects offspring gene expression and methylation of non-SMC subunits of condensin I in liver and skeletal muscle.Serine/threonine kinase, Melk, regulates proliferation and glial differentiation of retinal progenitor cells.PDLIM2 expression is driven by vitamin D and is involved in the pro-adhesion, and anti-migration and -invasion activity of vitamin D.Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity on multiple myeloma bone disease.
P2860
Q28245565-695A3DCE-4989-41AD-8720-A59435DD94EDQ33269159-0013199D-9066-4DFB-8EC5-FC1B19DFADE6Q33745060-FFBB52A2-FB94-401E-8CBE-0271AE96F800Q34992991-BC6B02D2-8243-4092-A26B-BBFE9320C5EAQ35069778-A38DB7A5-2FAD-4D2A-A0D4-822CD82E5AB1Q35569149-D185C75F-0B9B-44F4-85B3-0CADDBFE36F6Q36275700-EC84D516-0D4B-4C2F-932F-6FC9A277F150Q36973933-48E5DD2C-5E0D-4794-97F7-8E55C708F103Q37099799-9C877027-AB4D-46F9-BB31-7B7A91059CAEQ38197273-87E400EC-8549-49D7-A23F-08408ACFACABQ48003326-A3D61118-0008-40B2-9376-75E497AC5692Q48664813-0C57F2EC-5E1F-4FC7-B1C2-D7F47889E18AQ51069588-455BD568-3537-49CB-9183-EA3DC1735D8BQ54110801-17802297-E879-4858-8F0C-2EBFAE2AAD76
P2860
Characterization of the condensin component Cnap1 and protein kinase Melk as novel E2F target genes down-regulated by 1,25-dihydroxyvitamin D3.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Characterization of the conden ...... d by 1,25-dihydroxyvitamin D3.
@en
type
label
Characterization of the conden ...... d by 1,25-dihydroxyvitamin D3.
@en
prefLabel
Characterization of the conden ...... d by 1,25-dihydroxyvitamin D3.
@en
P2093
P2860
P50
P356
P1476
Characterization of the conden ...... d by 1,25-dihydroxyvitamin D3.
@en
P2093
Annemieke Verstuyf
Bart De Moor
Hein Te Riele
Ine Beullens
Lieve Verlinden
Mark Van Camp
Mathieu Bollen
Monique Beullens
Paul Van Hummelen
P2860
P304
37319-37330
P356
10.1074/JBC.M503587200
P407
P577
2005-09-06T00:00:00Z